Hyman James, Falak Umair, Storey Claire, Richardson Samuel, Moffatt Mariko, Aujayeb Avinash
Respiratory Department, Northumbria Healthcare NHS Foundation Trust, Northumbria Way, Cramlington, NE23 6NZ, Northumberland, UK.
Pulm Ther. 2023 Sep;9(3):367-375. doi: 10.1007/s41030-023-00232-0. Epub 2023 Jul 6.
Previous studies in 2018 and 2022 have suggested increasing inpatient burden of pneumothorax and widespread variation in management. Local trends have never been elucidated. Northumbria Healthcare NHS Foundation Trust (NHCT) has a well-established pleural service, serving just over 600,000. Thus, we set up a local retrospective study to look at trends in pneumothorax presentation, management strategies, length of stay, and recurrence.
A coding search for 'pneumothorax' was performed for all patients attending NHCT between 2010 and 2020 was performed with local Caldicott approval. A total of 1840 notes were analysed to exclude iatrogenic, traumatic, and paediatric events. After excluding those cases, 580 remained for further analysis, consisting of 183 primary pneumothoraces (PSP) and 397 secondary pneumothoraces (SSP).
Median age for PSP was 26.5 years (IQR 17) with 69% male, and for SSP 68 years (IQR 11.5), 62% male; 23.5% of PSP and 8.6% of SSP were never smokers. The proportion of smokers and ex-smokers has not really changed over time: > 65% every year have been smokers or ex-smokers. Yearly pneumothorax incidence shows a downward trend for PSP but upwards for SSP. Median length of stay (LoS) for PSP was 2 days (IQR 2), and SSP 5 days (IQR 8), with a clear downward trend. From 2010 to 2015 > 50% PSP were managed with drain, but in 2019-2020 at least 50% managed conservatively, with a significant reduction in aspiration. Trends of recurrence for PSP are increasing, whereas for SSP is decreasing. Seventy-six (20 PSP, 56 SSP) went for surgery at the index time with 5.3% recurrence (20% recurrence in those without surgery).
This is the first known analysis of pneumothorax trends in a large trust in the northeast of England. The data in this study have certain limitations, including the lack of information on the size of pneumothorax and frailty indicators that may influence the decision for conservative management. Additionally, there is a reliance on clinical coding, which can introduce potential inaccuracies, and not all patient notes were accessible for analysis. Updated larger datasets should help elucidate trends better.
2018年和2022年的既往研究表明气胸患者住院负担在增加,且治疗方式存在广泛差异。当地的趋势从未得到阐明。诺森比亚医疗保健国民保健服务信托基金(NHCT)拥有完善的胸膜服务,服务人口略超过60万。因此,我们开展了一项当地回顾性研究,以观察气胸的就诊趋势、治疗策略、住院时间和复发情况。
在获得当地考迪科特委员会批准后,对2010年至2020年间在NHCT就诊的所有患者进行了“气胸”编码搜索。共分析了1840份病历,以排除医源性、创伤性和儿科病例。排除这些病例后,剩余580例进行进一步分析,其中包括183例原发性气胸(PSP)和397例继发性气胸(SSP)。
PSP的中位年龄为26.5岁(四分位间距17),男性占69%;SSP的中位年龄为68岁(四分位间距11.5),男性占62%;23.5%的PSP和8.6%的SSP从不吸烟。吸烟者和既往吸烟者的比例随时间并未真正改变:每年超过65%为吸烟者或既往吸烟者。每年气胸发病率显示PSP呈下降趋势,而SSP呈上升趋势。PSP的中位住院时间为2天(四分位间距2),SSP为5天(四分位间距8),呈明显下降趋势。2010年至2015年,超过50%的PSP采用胸腔引流治疗,但在2019 - 2020年,至少50%采用保守治疗,胸腔穿刺抽吸显著减少。PSP的复发趋势在增加,而SSP的复发趋势在下降。76例(20例PSP,56例SSP)在初次就诊时接受了手术,复发率为5.3%(未手术者复发率为20%)。
这是对英格兰东北部一家大型信托基金中气胸趋势的首次已知分析。本研究中的数据有一定局限性,包括缺乏气胸大小和可能影响保守治疗决策的虚弱指标信息。此外,依赖临床编码可能会引入潜在的不准确之处,且并非所有患者病历都可用于分析。更新的更大数据集应有助于更好地阐明趋势。